Magnesium in acute myocardial infarction: Still an open question

Canadian Journal of Cardiology

Volumn 14, Issue 5, 1998, Pages 745-749

  Seelig, Mildred S ^b   Elin, Ronald J ^b   Antman, Elliott M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Acute myocardial infarction; Magnesium; Meta analysis; Reperfusion injury

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MAGNESIUM; NITRATE;

ACUTE HEART INFARCTION; BRADYCARDIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG INFUSION; HEART PROTECTION; HUMAN; HYPERMAGNESEMIA; HYPOTENSION; META ANALYSIS; MORTALITY; ORAL DRUG ADMINISTRATION; REPERFUSION; REVIEW; STATISTICAL MODEL; TIME;

ANIMALS; CANADA; CLINICAL TRIALS; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; META-ANALYSIS; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031835041     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995;345:669-85.
2. Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction - a double-blind study. Magnesium 1984;3:346-52.
3. Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality, Int J Cardiol 1986;12:175-83.
4. Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet 1986;i:234-6.
5. Rasmussen HS, Suenson M, McNair P, Norregard P, Balslev S. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study. Clin Cardiol 1987;10:351-6.
6. Rasmussen HS, Gronbaek M, Cintin C, Balslov S, Norregard P, McNair P. One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol 1988;11:377-81.
7. Abraham AS, Rosenmann D, Kramer M, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987;147:753-5.
8. Ising H, Bertschat F Ibe K, Stoboy V, Goossen C, Hengst G. Stress-induced Ca/Mg shifts and vascular response in animals and men, comparison to electrolyte alterations in myocardial infarction patients. Magnes Bull 1986;8:95-103.
9. Bertschat F, Ising H, Guenther T, Wolleitz M, Dollar T, Ibe K. Randomized magnesium therapy after acute myocardial infarction. Magnes Res 1988;1:104.
10. Golf SW, Temme H, Moebius T, Greaf V, Roka L, Homann J. [Magnesium therapy after acute myocardial infarction: chronologic sequence of biochemical blood parameters]. Magnes Bull 1988;10:119-23.
11. Ceremuzynski L, Jurgiel R, Kulakowski P, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J 1989;118:1333-4.
12. Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990;66:271-4.
13. 4Mg in the acute phase of myocardial infarct]. Rev Port Cardiol 1990;9:205-10.
14. Abraham AS. Treatment of patients with acute myocardial infarction with intravenous magnesium. Magnes Trace Elem 1990;9:177-85.
15. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553-8.
16. Rebentisch E, Ising H, Bertschat F, Sorgenfrei J. [Magnesium treatment during arrhythmias following myocardial infarction - therapeutic efficacy and electrolyte status]. Magnes Bull 1992;14:111-21.
17. Thogersen AM, Johnson O, Wester PO. Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction, Int J Cardiol 1993;39:13-22.
18. Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994;243:816-9.
19. Thogersen AM, Johnson O, Wester PO. Effects of intravenous magnesium sulfate in suspected acute myocardial infarction on arrhythmias and long-term outcome. Int J Cardiol 1995;49:143-51.
20. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995;75:321-3
21. Shechter M, Hod H, Kaplinsky E, Rabinowitz B. The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy. Am Heart J 1996;132(Suppl):483-6.
22. Rasmussen HS. Justification for intravenous magnesium therapy in acute myocardial infarction. Magnes Res 1988;1:59-73.
23. Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991;32:3-10.
24. Shechter M. The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature. Magnes Bull 1990;121:1-5.
25. Herzog WR, Serebruany VL. How magnesium therapy may influence clinical outcome in acute myocardial infarction: review of potential mechanisms. Coron Artery Dis 1996;7:364-70.
26. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991;303:1499-503.
27. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992;86:774-9.
28. Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985;5:280-9.
29. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985;76:1713-9.
30. Keren A, Dorian P, Davy JM, Opie LH. Effects of magnesium on ischemic and reperfusion arrhythmias in the rat heart and electrophysiologic effects of hypermagnesemia in the anesthetized dog. Cardiovasc Drugs Ther 1988;2:637-45.
31. Meus PJ, Javorski JJ, Mayer DB, Segil LJ, Miletich DJ. Magnesium increases survival and decreases ventricular fibrillation in swine myocardial infarction. FASEB J 1988;2:A919.
32. Ferrara N, Longobardi G, Abete P, et al. Electrical and mechanical actions of magnesium sulfate during ischemia and reperfusion on isolated perfused rat heart. Arch Int Pharmacodyn Ther 1988;293:84-96.
33. Bril A, Rochette L. Prevention of reperfusion-induced ventricular arrhythmias in isolated rat heart with magnesium. Can J Physiol Pharmacol 1990;68:694-9.
34. Ferrari R, Albertini A, Curello S, et al. Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium. J Mol Cell Cardiol 1986;18:487-98.
35. Nattel S, Turmel N, Macleod R, Solymoss BC. Actions of intravenous magnesium on ventricular arrhythmias caused by acute myocardial infarction. J Pharmacol Exp Ther 1991;259:939-46.
36. du Toit EF, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at reperfusion. Circ Res 1992;70:960-7.
37. Atar D, Serebruany V, Poulton J, Godard J, Schneider A, Herzog WR. Effects of magnesium supplementation in a porcine model of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 1994;24:603-11.
38. Bolli R. Mechanism of myocardial "stunning". Circulation 1990;82:723-38.
39. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-93.
40. Mergner GW, Weglicki WB, Kramer JH. Postischemic free radical production in the venous blood of the regionally ischemic swine heart. Effect of deferoxamine. Circulation 1991;84:2079-90.
41. Kramer JH, Misik V, Weglicki WB. Magnesium-deficiency potentiates free radical production associated with postischemic injury to rat hearts: vitamin E affords protection. Free Radic Biol Med 1994;16:713-23.
42. Hearse DJ. Cellular damage during myocardial ischaemia: metabolic changes leading to enzyme leakage. In: Hearse DJ, de Leiris J, Lotsance D, eds. Enzymes in Cardiology: Diagnosis and Research. New York: John Wiley, 1979:1-19.
43. Herzog WR, Atar D, Mak IT, Alyono D, MacCord C, Weglicki WB. Magnesium deficiency prolongs myocardial stunning in an open-chest swine model. Int J Cardiol 1994;47:105-15.
44. Herzog WR, Schlossberg ML, MacMurdy KS, et al. Timing of magnesium therapy affects experimental infarct size. Circulation 1995;92:2622-6.
45. Leor J, Kloner RA. An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995;75:1292-3.
46. Christensen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 1995;92:2617-21.
47. Barros LF, Chagas AC, da Luz PL, Pileggi F. Magnesium treatment of acute myocardial infarction: effects on necrosis in an occlusion/reperfusion dog model. Int J Cardiol 1995;48:3-9.
48. Antman EM. Magnesium in acute myocardial infarction: overview of available evidence. Am Heart J 1996;132(Suppl):487-95.
49. Nowak R. Problems in clinical trials go far beyond misconduct. Science 1994;264:1538-41.
50. Casscells W. Magnesium and myocardial infarction. Lancet 1994;343:807-9.
51. Heesch CM, Eichhorn EJ. Magnesium in acute myocardial infarction. Ann Emerg Med 1994;24:1154-60.
52. Simoes Fernandez J. Commentary on recent clinical advances: early intravenous magnesium administration in acute myocardial infarction. Magnes Res 1994;7:341-3.
53. Herzog WR. ISIS-4. Lancet 1995;345:1372. (Lett)
54. Antman EM. Magnesium in acute MI: timing is critical. Circulation 1995;92:2367-72. (Edit)
55. Antman EM. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol 1995;75:391-3. (Edit)
56. Seelig MS, Elin RJ. Reexamination of magnesium infusions in myocardial infarction. Am J Cardiol 1995;76:172-3. (Edit)
57. Seelig MS, Elm RJ. Is there a place for magnesium in the treatment of acute myocardial infarction? Am Heart J 1996;132(Suppl):471-7.
58. Antman EM, Seelig MS, Fleischmann K, et al. Magnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use. Cardiovasc Drugs Ther 1996;10:297-301. (Edit)
59. Feldstedt M, Boesgaard S, Bouchelouche P, et al. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J 1991;12:1215-8.
60. Stevenson RN, Keywood C, Amadi AA, Davies JR, Patterson DL. Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure. Br Heart J 1991;66:19-21.
61. Smetana R, Pacher R, Baumgartner W, et al. Moderate magnesium-sparing effect of high dosage ACE-inhibitor therapy in chronic heart failure. Magnes Bull 1994;16:98-100.
62. Flather M, Pipilis A, Collins R, et al. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. IS1S-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators. Eur Heart J 1994;15:608-19.
63. Aleksandrowicz J. Natural environment and man's health. In: Michajiow M, ed. Protection of Man's Natural Environment. Warsaw: Polish Sci Publ, 1973:518-28.
64. Crawford MD, Gardner MJ, Morris JN. Changes in water hardness and local death rates. Lancet 1971;ii:327-9.
65. Yusuf S, Flather M. Magnesium in acute myocardial infarction. BMJ 1995;310:750-2. (Edit)